Fundraising Fox

Talus Bio

YC S21 ↗

Seattle, US · Founded 2020 · Delaware corporation · 16 employees · 7 known investors

talus.bio ↗

Talus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts. The company designs AI-driven compounds and uses functional proteomics to enable drug discovery for transcription factors and regulatory proteins implicated in oncology, rare disease, and immune dysfunction.

AI & Machine LearningBiotechDeep TechHealthtechGenomicsDrug discoveryin /talus-bio/@talusbioycombinator.com ↗

Founders & leadership· Y Combinator alumni (S21)

AFAlex Federation
Alex Federationin𝕏Founder
LPLindsay Pino
Lindsay Pinoin𝕏Founder
OA
Omri Amirav-DroryDirector
JS
J. Seth StrattanDirector
CJChristopher Joyce
Christopher Joycein
MBMichelle Briscoe
Michelle Briscoein
WFWill Fondrie
Will Fondriein

Investors · 7

Farvatn VentureBergen
Fifty YearsSan Francisco · $250K – $2M
FundersClubSan Francisco · $250K – $5M
Two Bear CapitalWhitefish · $3M – $10M
Y CombinatorSan Francisco · $500K
BoxOne VenturesreportedMontréal · $500K
NFXreported · 2 sourcesSan Francisco · $250K – $5Mvia Omri Amirav-Drory · board

Reported raises · per SEC filings

Form D private placements
▶$9.4MraisedAug 2024 · 11 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Lindsay PinoExecutive Officer, Director
  • Michelle BriscoeExecutive Officer
  • Alex FederationExecutive Officer, Director, Promoter
  • Omri Amirav-DroryDirector
  • J. Seth StrattanDirector
Offering amount
$11.3M
Amount sold
$9.4M
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news